Indeed, mice with cardiac-specific deletion of PPARD develop age-dependent cardiac lipotoxicity, cardiac hypertrophy, end-stage dilated cardiomyopathy, and decreased survival [55]. This evidence concerns the gene PPARD and cardiac hypertrophy.